Final report of University Hospital Hradec Kralove to the clinical trial protocol no. OMB112517

Abstract

A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no furthertreatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded to induction therapy

Keywords

• ofatumumab
• chronic lymphocytic leukemia (CLL)